TipRanks
Advertisement
Advertisement

AU:AGN Stock Latest News

Argenica Director Boosts Direct Shareholding in On-Market Trade
Company AnnouncementsArgenica Director Boosts Direct Shareholding in On-Market Trade
4m ago
AGN
Argenica Sets 2026 AGM Date and Director Nomination Deadline
PremiumCompany Announcements
Argenica Sets 2026 AGM Date and Director Nomination Deadline
6d ago
AGN
Argenica’s xaranetide concussion data earns international neurotrauma spotlight
PremiumCompany Announcements
Argenica’s xaranetide concussion data earns international neurotrauma spotlight
14d ago
AGN
Argenica Files 2026 Corporate Governance Statement with ASX
PremiumCompany Announcements
Argenica Files 2026 Corporate Governance Statement with ASX
1M ago
AGN
Argenica Narrows Annual Loss as R&D Support Boosts Revenue
PremiumCompany Announcements
Argenica Narrows Annual Loss as R&D Support Boosts Revenue
1M ago
AGN
Argenica Options Lapse Trims Potential Diluted Capital
PremiumCompany AnnouncementsArgenica Options Lapse Trims Potential Diluted Capital
2M ago
AGN
Argenica Highlights Neuroprotection Strategy in New Investor Briefing
Premium
Company Announcements
Argenica Highlights Neuroprotection Strategy in New Investor Briefing
2M ago
AGN
WHO Confirms International Generic Name for Argenica’s Lead Stroke Drug
Premium
Company Announcements
WHO Confirms International Generic Name for Argenica’s Lead Stroke Drug
4M ago
AGN
Argenica Options Lapse Clarifies Capital Structure
PremiumCompany Announcements
Argenica Options Lapse Clarifies Capital Structure
4M ago
AGN
Argenica Advances ARG-007 Stroke Program and Strengthens Funding for Phase 2b Trial
PremiumCompany Announcements
Argenica Advances ARG-007 Stroke Program and Strengthens Funding for Phase 2b Trial
5M ago
AGN
Argenica boosts cash reserves with $3.97m R&D rebate to advance stroke drug
PremiumCompany Announcements
Argenica boosts cash reserves with $3.97m R&D rebate to advance stroke drug
7M ago
AGN
Argenica Widens Half-Year Loss as ARG-007 Stroke Trial Spending Climbs
PremiumCompany Announcements
Argenica Widens Half-Year Loss as ARG-007 Stroke Trial Spending Climbs
8M ago
AGN
Argenica Wins EMA Paediatric Waiver, Streamlining EU Pathway for Stroke Drug ARG-007
PremiumCompany AnnouncementsArgenica Wins EMA Paediatric Waiver, Streamlining EU Pathway for Stroke Drug ARG-007
8M ago
AGN
Argenica’s AI Analysis Confirms ARG-007 Efficacy in Severe Stroke, Paving Way for Phase 2b Trial
Premium
Company Announcements
Argenica’s AI Analysis Confirms ARG-007 Efficacy in Severe Stroke, Paving Way for Phase 2b Trial
8M ago
AGN
Argenica Therapeutics Announces Departure of Director Di Angus
Premium
Company Announcements
Argenica Therapeutics Announces Departure of Director Di Angus
9M ago
AGN
Argenica Chair Steps Down as Biotech Prepares for Next Growth Phase
PremiumCompany Announcements
Argenica Chair Steps Down as Biotech Prepares for Next Growth Phase
9M ago
AGN
Argenica’s ARG-007 Shows Promising Results in Severe Stroke Patients
PremiumCompany Announcements
Argenica’s ARG-007 Shows Promising Results in Severe Stroke Patients
10M ago
AGN
Argenica’s ARG-007 Shows Promising Results in Preclinical Stroke Study
PremiumCompany Announcements
Argenica’s ARG-007 Shows Promising Results in Preclinical Stroke Study
10M ago
AGN
Argenica Therapeutics AGM Resolutions Passed Successfully
PremiumCompany Announcements
Argenica Therapeutics AGM Resolutions Passed Successfully
11M ago
AGN
Argenica Therapeutics Advances ARG-007 Amidst Clinical and Market Challenges
PremiumCompany AnnouncementsArgenica Therapeutics Advances ARG-007 Amidst Clinical and Market Challenges
11M ago
AGN
Argenica Therapeutics Announces Retirement of Key Board Member
Premium
Company Announcements
Argenica Therapeutics Announces Retirement of Key Board Member
11M ago
AGN
Argenica Therapeutics Advances Stroke Treatment with Promising Trial Results
Premium
Company Announcements
Argenica Therapeutics Advances Stroke Treatment with Promising Trial Results
11M ago
AGN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >